SCHEMBL8099405

SCHEMBL8099405

Nc1cc(C2(S(=O)(=O)c3ccncc3)CC2)nc(-c2ccc(NC(=O)NC3CC3)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.42
NAMPT P43490 6/20 0.40
PIK3CA P42336 3/20 0.40
MTOR P42345 3/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
GAA P10253 1/20 0.37
RAB9A P51151 1/20 0.37
RORC P51449 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
KLKB1 P03952 1/20 0.36
KIT P10721 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8098812 0.90 NPC1 (0.43) EPHX1CA12CA1CA2CA9
SCHEMBL8084016 0.88 CA12 (0.41) EPHX1NAMPTPIK3CAMTORCA12
SCHEMBL8090948 0.88 CA12 (0.41) EPHX1NAMPTPIK3CAMTORCA12
SCHEMBL8084833 0.88 CA12 (0.43) EPHX1NAMPTCA12CA1CA2
SCHEMBL8099749 0.88 MTOR (0.40) NAMPTPIK3CAMTORKMT2A
SCHEMBL8098814 0.87 EPHX1 (0.47) EPHX1CA12CA1CA2CA9
SCHEMBL8093179 0.87 RAB9A (0.42) EPHX1PIK3CAMTORCA12CA1
SCHEMBL8090868 0.87 MTOR (0.38) NAMPTPIK3CAMTORKDM4EMEN1
SCHEMBL8091191 0.86 PIK3CA (0.40) PIK3CAMTORCA12CA1CA2
SCHEMBL8092850 0.85 CA12 (0.42) NAMPTPIK3CAMTORCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed